ADAP

World AIDS Day: More Funding for HIV Cure, Global Fund, No One on ADAP Wait List

Acknowledging World AIDS Day on December 1, President Obama announced that the National Institutes of Health (NIH) would reallocate $100 million over the next 3 years towards HIV cure research and donate up to $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria. In other funding news, NASTAD announced last week that there are currently no people with HIV on AIDS Drug Assistance Program (ADAP) waiting lists.

alt

Read more:

ADAP Crisis Task Force and ViiV Agree on Discounted Price for Dolutegravir

The ADAP Crisis Task Force (ACTF) announced this week that it has negotiated an agreement with ViiV Healthcare to provide the newly approved integrase inhibitor dolutegravir (Tivicay) to AIDS Drug Assistance Program (ADAP) recipients for less than the wholesale cost.

alt

Read more:

Increased Federal Funding Will Eliminate ADAP Wait Lists

In advance of the International AIDS Conference in Washington, DC, Health and Human Services Secretary Kathleen Sebelius announced that the federal government has allocated nearly $800 million in additional funding for domestic HIV/AIDS programs, which should allow everyone now on state waiting lists to access treatment.alt

Read more:

HIV Medical Providers Call for Fair Drug Pricing to Expand Access to Treatment

Practitioners from the American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA) delivered a joint statement to pharmaceutical company executives this week, asking the industry to reconsider its pricing for antiretroviral drugs so that more people in the U.S. and worldwide are able to access treatment. alt

Read more:

Companies Lower HIV Drug Prices for ADAP, but Many Patients Still Waiting

Four pharmaceutical companies recently agreed to discount their prices on altantiretroviral drugs for AIDS Drug Assistance Programs (ADAPs), which are under increasing pressure due to the ongoing financial crisis. More than 4000 people with HIV are currently on ADAP waiting lists, most of them in the Southeast U.S.

Read more: